184576-20-3

Basic information

• Product Name: 4-(N-benzyloxycarbonyl)glycyl-1-tert-butoxycarbonylmethyl-2-oxopiperazine-3-acetic acid
• Synonyms: 4-(N-benzyloxycarbonyl)glycyl-1-tert-butoxycarbonylmethyl-2-oxopiperazine-3-acetic acid
• CAS NO: 184576-20-3
• Molecular Weight: 463.488
• Mol File: 184576-20-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(N-benzyloxycarbonyl)glycyl-1-tert-butoxycarbonylmethyl-2-oxopiperazine-3-acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(N-benzyloxycarbonyl)glycyl-1-tert-butoxycarbonylmethyl-2-oxopiperazine-3-acetic acid(184576-20-3)
• EPA Substance Registry System: 4-(N-benzyloxycarbonyl)glycyl-1-tert-butoxycarbonylmethyl-2-oxopiperazine-3-acetic acid(184576-20-3)

Safety Data

• Hazardous Substances Data: 184576-20-3(Hazardous Substances Data)

Upstream product

• 7646-93-7 potassium hydrogensulfate 
• 184576-61-2 4-(N-benzyloxycarbonyl)glycyl-1-tert-butoxycarbonylmethyl-2-oxopiperazine-3-acetic acid methyl ester 

Relevant articles and documents

Freeze-dried preparation for pharmaceutical use

A freeze-dried preparation comprising a bioactive substance having an optionally substituted amidino group and a disaccharide which stabilizes the bioactive substance; and a process for making the preparation are described.

Piperazinones, their production and use

The present invention provides compounds and medicines effective for prophylaxis and therapy of various diseases by controlling or inhibiting cell-adhesion. Especially, the compounds of this invention perform platelet aggregation action without remarkable